News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

FDA Panel Recommends Keeping GlaxoSmithKline (GSK)'s Avandia On US Market, But With More Warnings, Restrictions


7/14/2010 2:27:23 PM

WASHINGTON (Dow Jones)--A Food and Drug Administration panel voted Wednesday to recommend that GlaxoSmithKline PLC's (GSK) diabetes drug, Avandia, remain on the market despite concerns the product could raise the risk of heart attacks.

Read at Wall Street Journal
Read at Los Angeles Times
Read at Business Week
Read at Market Watch
Read at News Release
Read at New York Times
Read at AP
Read at News Release


comments powered by Disqus
   
Diabetes

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES